Extension of Time to File SOU

REJENEVIE

Advanced ReGen Medical Technologies, LLC

Request for Extension of Time to File a Statement of Use

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88281350
LAW OFFICE ASSIGNED LAW OFFICE 101
MARK SECTION
MARK REJENEVIE (see, http://uspto.report/TM/88281350/mark.png)
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT REJENEVIE
OWNER SECTION (current)
NAME Advanced ReGen Medical Technologies, LLC
MAILING ADDRESS 3 Greenway Plaza, Suite 1000
CITY Houston
STATE Texas
ZIP/POSTAL CODE 77046
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
OWNER SECTION (proposed)
NAME Advanced ReGen Medical Technologies, LLC
MAILING ADDRESS 3 Greenway Plaza, Suite 1000
CITY Houston
STATE Texas
ZIP/POSTAL CODE 77046
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
ATTORNEY INFORMATION (current)
NAME Thomas Y. Yee
ATTORNEY BAR MEMBERSHIP NUMBER NOT SPECIFIED
YEAR OF ADMISSION NOT SPECIFIED
U.S. STATE/ COMMONWEALTH/ TERRITORY NOT SPECIFIED
FIRM NAME KNOBBE MARTENS OLSON & BEAR LLP
INTERNAL ADDRESS 14TH FLOOR
STREET 2040 MAIN STREET
CITY IRVINE
STATE California
POSTAL CODE 92614
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
PHONE 949-760-0404
FAX 949-760-9502
EMAIL efiling@knobbe.com
DOCKET/REFERENCE NUMBER ARGMT.010T
ATTORNEY INFORMATION (proposed)
NAME Thomas Y. Yee
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME KNOBBE MARTENS OLSON & BEAR LLP
INTERNAL ADDRESS 14TH FLOOR
STREET 2040 MAIN STREET
CITY IRVINE
STATE California
POSTAL CODE 92614
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
PHONE 949-760-0404
FAX 949-760-9502
EMAIL efiling@knobbe.com
DOCKET/REFERENCE NUMBER ARGMT.010T
OTHER APPOINTED ATTORNEY John B. Sganga, Jr., Edward A. Schlatter, Gerard von Hoffmann, Joseph R. Re, Catherine J. Holland, John M. Carson, Jeffrey L. Van Hoosear, Daniel E. Altman, Lynda J. Zadra-Symes, William H. Shreve, Stephen C. Jensen, Steven J. Nataupsky, Paul A. Stewart, Joseph F. Jennings, Craig S. Summers, Diane M. Reed, Ronald J. Schoenbaum, John R. King, Adeel S. Akhtar, David N. Weiss, Douglas G. Muehlhauser, Lori Lee Yamato, Michael K. Friedland, Stacey R. Halpern, Mark M. Abumeri, Jon W. Gurka, Joseph M. Reisman, Michael L. Fuller, Paul N. Conover, Robert J. Roby, Sabing H. Lee, Karoline A. Delaney, Joseph S. Cianfrani, William R. Zimmerman, Eric S. Furman, Susan M. Natland, Rose M. Thiessen, Michael A. Guiliana, Rabinder N. Narula, Bruce S. Itchkawitz, John M. Grover, Irfan A. Lateef, Amy Christensen Chun, Mark J. Gallagher, David G. Jankowski, Brian C. Horne, Payson LeMeilleur, Sheila N. Swaroop, Benjamin A. Katzenellenbogen, Andrew N. Merickel, Thomas P. Krzeminski, Linda H. Liu, James F. Herkenhoff, Andrew M. Douglas, Salima A. Merani, Jonathan A. Hyman, Curtiss C. Dosier, Joseph J. Mallon, Sean M. Murray, Christy G. Lea, Perry D. Oldham, Russell M. Jeide, Zi Y. Wong, Matthew S. Bellinger, Mincheol Kim, Gregory A. Hermanson, Lauren Keller Katzenellenbogen, Ted M. Cannon, Carol Pitzel Cruz, Josué A. Villalta, Andrew I. Kimmel, Brenden Gingrich, Maria Culic Anderson, Melanie J. Seelig, Mauricio A. Uribe, Curtis R. Huffmire, Christopher L. Ross, Eli A. Loots, Ryan E. Melnick, Yanna S. Bouris, Philip M. Nelson, Marko R. Zoretic, Kerry S. Taylor, Derek C. Dailey, Jarom D. Kesler, Colin B. Heideman, Theodore G. Papagiannis, Nicholas M. Zovko, Adam J. Gilbert, Kimberly J. Miller, Bryan W. Wahl, Thomas Y. Yee, Agnes Juang, Jason J. Jardine, Jared C. Bunker, Lance D. Smemoe, Joshua J. Stowell, Jonathan E. Bachand, Ali S. Razai, Terry K. Tullis, Derek R. Bayles, Cheryl T. Burgess, Gregory B. Phillips, Brian C. Claassen, Mark Lezama, Sean Ambrosius, Stephen W. Larson, John L. Paik, Michael R. Christensen, Benjamin J. Everton, Jason A. Gersting, Baraa Kahf, Alan G. Laquer, Vlad Teplitskiy, Jeffery L. Hallstrom, Maria V. Stout, William O. Adams, Ian W. Gillies, Andrew W. Lloyd, Mark D. Kachner, Lincoln S. Essig, David R. Trossen, Aaron M. Davis, Jason R. Swartz, Benjamin B. Anger, Jason A. Champion, Daniel V. Gibson, Jeremy J. Carney, Karen M. Cassidy, Adam B. Powell, Karen J. Lenker, Bryan G. McWhorter, Nathanael R. Luman, Andrea L. Cheek, Damien J. Howard, Jane Q. Dai, Shannon Lam, Peter Law, Mark Metzke, Jacob Peterson, Christie R.W. Matthaei, Vladimir S. Lozan, Paul S. Stellman, Heungsoo Choi, Nicole Rossi Townes, Vikas Bhargava, Daniel J. Fischer, Jeremy A. Anapol, Scott A. Cromar, Kendall M. Loebbaka, David R. Schmidt, Harnik Shukla, Charlene A. Azema, Morgan R. Coates, Jessica L. Achtsam, Jonathan A. Menkes, Rosaleen H. Chou, Deborah S. Shepherd, Mark D. Marsden, Joan Y. Chan, Loni L. Morrow, Kyu S. Min, Chang Sik Lim, Thomas S.H. Cowan, Devanie A. DuFour, Alexander J. Martinez, Hans L. Mayer, Jessica C. Sganga, Nicholas A. Belair, Ryan S. Furtado, Angela K. Dremann, Justin J. Gillett, M. Scott Forbes, Brian M. Graham, Brian J. Flynn, Mitchell B. Hadley, Elenore Niu, Michael P. Burns, David M. Cohen, Mark E. Davis, Jordan Gottdank, Kim A. Kennedy, Daniel C. Kiang, Keith M. Lim, Ashley C. Morales, Nathan D. Reeves, Brandon G. Smith, Xiaoyan Sabrina Wang, Jun Hyuk (Zach) Hong, Jordan M. Cox, Albert J. Sueiras, Mark Rubinshtein, David J. Grant, Clayton R. Henson, Daniel A. Kamkar, Lesley Y. Kim, Nathan J. Lee, Josepher Li, Jacob R. Rosenbaum, James F. Smith, Douglas B. Wentzel, Aryeh N. Feinstein, Noorean I. Gill, Aaron S. Johnson, Bryan J. Johnson, Chanell Khosrowabadi, Lindsay A. Laddaran, Janet M. Allendorph, Alexander Zeng, Sean S. Kim, Benjamin Ho, Adam R. Aquino, Samuel I. Cockriel, Serah R. Friedman, Bita Kianian, Eric R. Malmgren, Brian M.Z. Reece, Derk A. Westermeyer, Suyoung Jang, Show Xiaoyu Wang, Justin E. Culbertson, Andrew E. Morrell, Victoria E. Ellis, Yasmin L. Amin-Reimer, Kendrick S. Hsu, Catherine R. Gourash, Marissa M. Rosenbaum, Brok S. Humbert, Karl W. Kowallis, Christopher L. Lewis, Ryan L. McBride, Atiya M. Myers, David C. O'Hair, Radhika K. Raman, Ben K. Shiroma, Makoto Tsunozaki, James Yang, Jeremiah S. Helm, Hironori Kubota, Kregg A. Koch, Arsen Kourinian, James E. Youngblood, Andrew D. Lee, Yusuke Hirai, and Sunyong Tang
CORRESPONDENCE INFORMATION (current)
NAME THOMAS Y. YEE
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE efiling@knobbe.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
DOCKET/REFERENCE NUMBER ARGMT.010T
CORRESPONDENCE INFORMATION (proposed)
NAME Thomas Y. Yee
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE efiling@knobbe.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
DOCKET/REFERENCE NUMBER ARGMT.010T
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 001
CURRENT IDENTIFICATION Chemical test kits for determining patient candidacy and condition for procedure for rejuvenating and regenerating patient cells in connection with clinical or medical laboratory use
GOODS OR SERVICES KEEP ALL LISTED
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Pre-packaged kits for use in regeneration and rejuvenation of patient cells for medical purposes, namely, kits comprising vials for containing cells, young donor cells, regeneration and rejuvenation media, small molecule and nucleotide-based therapeutics for cellular regeneration and rejuvenation, and transwell cell culture plates; Pharmaceutical preparations for regeneration and rejuvenation of patient cells; pharmaceutical preparations, namely, pharmaceutical preparations for use in regenerative medicine, oncology and treatment of infectious disease; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, antibodies, cell permeable and non-permeable fluorescent dyes, and radioisotopes
GOODS OR SERVICES KEEP ALL LISTED
INTERNATIONAL CLASS 010
CURRENT IDENTIFICATION Medical apparatus for use in patient cell collection and in treating patient cells in a transwell system to restore patient immune function and treat inflammatory-induced disorders, arthritis, atherosclerosis, breast cancer, cardiovascular disease, cataracts, chronic obstructive pulmonary disease, colorectal cancer, hypertension, osteoporosis, periodontitis, type 2 diabetes, immune dysfunction, Alzheimer's disease, leukemia, lymphoma, multiple sclerosis, Crohn's disease, HIV, influenza, pneumonia, lung cancer, melanoma, stroke, Parkinson's disease, and multiple drug resistant staphylococcus aureus ; apparatus for the regeneration and rejuvenation of stem cells, cells and tissue for medical purpose; human cell specimen collection kit comprising centrifuge tubes, absorbent cloth, and instructions, all for medical use
GOODS OR SERVICES KEEP ALL LISTED
INTERNATIONAL CLASS 035
CURRENT IDENTIFICATION Business management and consultancy services; Business data analysis services in the field of healthcare; data processing and database management services for the healthcare industry
GOODS OR SERVICES KEEP ALL LISTED
INTERNATIONAL CLASS 040
CURRENT IDENTIFICATION Cryogenic preservation; Stem cell, cell, and tissue cryogenic preservation
GOODS OR SERVICES KEEP ALL LISTED
INTERNATIONAL CLASS 042
CURRENT IDENTIFICATION Data mining; data hosting services, namely, hosting of digital content on the internet for others; data hosting services, namely, hosting of healthcare and patient data on the internet for others
GOODS OR SERVICES KEEP ALL LISTED
INTERNATIONAL CLASS 044
CURRENT IDENTIFICATION Medical services; medical clinics; medical information; providing clinical testing information services for the diagnosis monitoring and treatment of disease for medical purposes; Medical services, namely, cell and stem cell mobilization, collection, isolation, processing, banking, implantation, explantation and transfer; liposuction; medical services in the fields of anti-aging, immunoncology, and vaccines; medical services for cell, stem cell and tissue rejuvenation and regeneration
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 1
ALLOWANCE MAIL DATE 10/15/2019
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 7
SUBTOTAL AMOUNT [EXTENSION FEE] 875
TOTAL AMOUNT 875
SIGNATURE SECTION
SIGNATURE /Marissa M. Rosenbaum/
SIGNATORY'S NAME Marissa M. Rosenbaum
SIGNATORY'S POSITION Attorney of record, Associate Attorney, Knobbe, Martens, Olson & Bear LLP, California bar member
DATE SIGNED 04/14/2020
SIGNATORY'S PHONE NUMBER 949-760-0404
FILING INFORMATION
SUBMIT DATE Tue Apr 14 18:40:49 ET 2020
TEAS STAMP USPTO/ESU-XXX.XXX.XX.XX-2
0200414184049336029-88281
350-71027bd8a81e362193d44
1939decdb5bfa7d75445cf95f
759f75dfbbd798431b8a-CC-4
0475491-20200414165422078
917



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: REJENEVIE (see, http://uspto.report/TM/88281350/mark.png)
SERIAL NUMBER: 88281350

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Advanced ReGen Medical Technologies, LLC, having an address of
      3 Greenway Plaza, Suite 1000
      Houston, Texas 77046
      United States
Proposed: Advanced ReGen Medical Technologies, LLC, having an address of
      3 Greenway Plaza, Suite 1000
      Houston, Texas 77046
      United States
      Phone:
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 10/15/2019.

For International Class 001:
Current identification: Chemical test kits for determining patient candidacy and condition for procedure for rejuvenating and regenerating patient cells in connection with clinical or medical laboratory use

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


For International Class 005:
Current identification: Pre-packaged kits for use in regeneration and rejuvenation of patient cells for medical purposes, namely, kits comprising vials for containing cells, young donor cells, regeneration and rejuvenation media, small molecule and nucleotide-based therapeutics for cellular regeneration and rejuvenation, and transwell cell culture plates; Pharmaceutical preparations for regeneration and rejuvenation of patient cells; pharmaceutical preparations, namely, pharmaceutical preparations for use in regenerative medicine, oncology and treatment of infectious disease; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, antibodies, cell permeable and non-permeable fluorescent dyes, and radioisotopes

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


For International Class 010:
Current identification: Medical apparatus for use in patient cell collection and in treating patient cells in a transwell system to restore patient immune function and treat inflammatory-induced disorders, arthritis, atherosclerosis, breast cancer, cardiovascular disease, cataracts, chronic obstructive pulmonary disease, colorectal cancer, hypertension, osteoporosis, periodontitis, type 2 diabetes, immune dysfunction, Alzheimer's disease, leukemia, lymphoma, multiple sclerosis, Crohn's disease, HIV, influenza, pneumonia, lung cancer, melanoma, stroke, Parkinson's disease, and multiple drug resistant staphylococcus aureus ; apparatus for the regeneration and rejuvenation of stem cells, cells and tissue for medical purpose; human cell specimen collection kit comprising centrifuge tubes, absorbent cloth, and instructions, all for medical use

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


For International Class 035:
Current identification: Business management and consultancy services; Business data analysis services in the field of healthcare; data processing and database management services for the healthcare industry

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


For International Class 040:
Current identification: Cryogenic preservation; Stem cell, cell, and tissue cryogenic preservation

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


For International Class 042:
Current identification: Data mining; data hosting services, namely, hosting of digital content on the internet for others; data hosting services, namely, hosting of healthcare and patient data on the internet for others

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


For International Class 044:
Current identification: Medical services; medical clinics; medical information; providing clinical testing information services for the diagnosis monitoring and treatment of disease for medical purposes; Medical services, namely, cell and stem cell mobilization, collection, isolation, processing, banking, implantation, explantation and transfer; liposuction; medical services in the fields of anti-aging, immunoncology, and vaccines; medical services for cell, stem cell and tissue rejuvenation and regeneration

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the first extension request.

The applicant's current Attorney Information:
      Thomas Y. Yee      KNOBBE MARTENS OLSON & BEAR LLP

      14TH FLOOR
      2040 MAIN STREET
      IRVINE, California 92614
      United States
      Phone: 949-760-0404
      Fax: 949-760-9502
      The docket/reference number is ARGMT.010T
      Email: efiling@knobbe.com


The applicant's proposed Attorney Information:
      Thomas Y. Yee      KNOBBE MARTENS OLSON & BEAR LLP

      14TH FLOOR
      2040 MAIN STREET
      IRVINE, California 92614
      United States
      Phone: 949-760-0404
      Fax: 949-760-9502
      The docket/reference number is ARGMT.010T
      Email: efiling@knobbe.com


Correspondence Information (current):
      THOMAS Y. YEE
      PRIMARY EMAIL FOR CORRESPONDENCE: efiling@knobbe.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED

Correspondence Information (proposed):
      Thomas Y. Yee
      PRIMARY EMAIL FOR CORRESPONDENCE: efiling@knobbe.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $875 will be submitted with the form, representing payment for 7 classes.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /Marissa M. Rosenbaum/      Date Signed: 04/14/2020
Signatory's Name: Marissa M. Rosenbaum
Signatory's Position: Attorney of record, Associate Attorney, Knobbe, Martens, Olson & Bear LLP, California bar member
Signatory's Phone: 949-760-0404

Mailing Address:
   KNOBBE MARTENS OLSON & BEAR LLP
   14TH FLOOR
   2040 MAIN STREET
   IRVINE, California 92614

RAM Sale Number: 88281350
RAM Accounting Date: 04/14/2020

Serial Number: 88281350
Internet Transmission Date: Tue Apr 14 18:40:49 ET 2020
TEAS Stamp: USPTO/ESU-XXX.XXX.XX.XX-2020041418404933
6029-88281350-71027bd8a81e362193d441939d
ecdb5bfa7d75445cf95f759f75dfbbd798431b8a
-CC-40475491-20200414165422078917




uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed